Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Boehringer Ingelheim
Fuji
UBS
McKesson
Federal Trade Commission
Argus Health
Harvard Business School

Generated: January 16, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Inotuzumab ozogamicin

« Back to Dashboard

US Patents for Inotuzumab ozogamicin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Inotuzumab ozogamicin ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Inotuzumab ozogamicin ➤ Sign Up Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics LLC (San Diego, CA) ➤ Sign Up
Inotuzumab ozogamicin ➤ Sign Up Processes for making hydrazides Wyeth LLC (Madison, NJ) ➤ Sign Up
Inotuzumab ozogamicin ➤ Sign Up P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up
Inotuzumab ozogamicin ➤ Sign Up Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics, LLC (San Diego, CA) ➤ Sign Up
Inotuzumab ozogamicin ➤ Sign Up Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Array BioPharma, Inc. (Boulder, CO) Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
Inotuzumab ozogamicin ➤ Sign Up Processes for making hydrazides Wyeth LLC (Madison, NJ) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Inotuzumab ozogamicin

Drugname Country Document Number Estimated Expiration Related US Patent
Inotuzumab ozogamicin Australia 2010266032 2026-06-23 ➤ Sign Up
Inotuzumab ozogamicin Canada 2765727 2026-06-23 ➤ Sign Up
Inotuzumab ozogamicin European Patent Office 2446031 2026-06-23 ➤ Sign Up
Inotuzumab ozogamicin Japan 2012531431 2026-06-23 ➤ Sign Up
Inotuzumab ozogamicin World Intellectual Property Organization (WIPO) 2010151703 2026-06-23 ➤ Sign Up
Inotuzumab ozogamicin World Intellectual Property Organization (WIPO) 2010151707 2026-06-23 ➤ Sign Up
Inotuzumab ozogamicin Argentina 066674 2027-05-22 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
UBS
Johnson and Johnson
Healthtrust
Covington
Express Scripts
Dow
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.